Results for tag: "Romiplostim"

Romiplostim is a hematological drug used to treat thrombocytopenia, a condition characterized by a low platelet count. It is a recombinant form of thrombopoietin, a naturally occurring hormone that stimulates the production of platelets. Romiplostim is administered as a subcutaneous injection and is approved for use in adults with chronic immune thrombocytopenia (ITP). It is also used off-label to treat other hematological conditions, such as aplastic anemia and myelodysplastic syndrome. Romiplostim is a relatively new drug, having been approved by the US Food and Drug Administration (FDA) in 2008. It is the only thrombopoietin receptor agonist approved for use in the United States. It is also approved for use in the European Union, Canada, Australia, and other countries. Romiplostim is marketed by several companies, including Amgen, Novartis, and Teva Pharmaceuticals. It is also available as a generic drug in some countries. Show Less Read more